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Cardiac sympathetic nerve activity is changed in patients with
hypertrophic cardiomyopathy (HCM). However, the relationship
between heterogeneity of this activity and systolic left ventric-
ular dysfunction in patients with HCM is not well established.
This study was performed to evaluate the sympathetic nerve
activity in various cardiac regions and to investigate the rela-
tionship between cardiac dysfunction and heterogeneity of the
cardiac sympathetic nerve activity in patients with HCM. Meth-
ods: Cardiac sympathetic nerve activity was evaluated in 25
patients with HCM and 10 control subjects using planar imaging
and SPECT by 123I-metaiodobenzylguanidine (MIBG) myocar-
dial scintigraphy. With planar 123I-MIBG imaging, the heart-to-
mediastinum activity ratios (H/M), at early (20 min) and delayed
(3 h) acquisition, and the washout rate were calculated. Polar
maps of the left ventricular myocardium were divided into 20
segments, and the dispersion (maximal to minimal values) and
SD of uptake and the washout rate in 20 segments were calcu-
lated. Results: The early H/M did not differ between the 2
groups. The delayed H/M was significantly lower and the wash-
out rate of the whole heart was significantly higher in the HCM
group than those in the control group. In patients with HCM, the
delayed H/M, early uptake dispersion, and SD of early uptake
showed good correlation with the left ventricular end-diastolic
and end-systolic dimensions and the percentage of fractional
shortening. A stepwise regression analysis revealed that the SD
of early uptake was a powerful determinant for the percentage
of fractional shortening in patients with HCM. Conclusion:
These results suggest that the heterogeneity of regional cardiac
sympathetic nerve activity may be correlated with cardiac dys-
function in patients with HCM.
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Hypertrophic cardiomyopathy (HCM) is an inherited
cardiac muscle disease and can be caused by a mutation in
the genes that encode proteins in the sarcomere (1,2). Mor-
phologic and functional characteristics of HCM include
disproportionate left ventricular hypertrophy and diastolic
dysfunction. However, some patients with HCM have sys-
tolic dysfunction and show dilated cardiomyopathy-like fea-
tures (3,4). Using 123I-metaiodobenzylguanidine (MIBG)
myocardial scintigraphy, we reported that patients with
HCM and systolic dysfunction have an increased 123I-MIBG
clearance (5). In addition, Brush et al. (6) found decreased
neuronal uptake and metabolism of norepinephrine in pa-
tients with HCM. These results suggest that cardiac sympa-
thetic nerve activity may play an important role in the
maintenance of cardiac function in patients with HCM.
However, the relationship between cardiac dysfunction and
change in homogeneity of regional cardiac sympathetic
nerve activity in patients with HCM is unclear. This study
was performed to evaluate the sympathetic nerve activity in
various cardiac regions and to investigate the relationship
between cardiac dysfunction and heterogeneity of the car-
diac sympathetic nerve activity in patients with HCM.
MATERIALS AND METHODS
Patients
The study group consisted of 25 patients with HCM (19 men, 6
women; mean age, 48.5  12.7 y) and 10 age- and sex-matched
control subjects (7 men, 3 women; mean age, 49.8  15.2 y). The
diagnosis of HCM was based on the echocardiographic demon-
stration of a nondilated, hypertrophied left ventricle in the absence
of other cardiac or systemic causes for the left ventricular hyper-
trophy (7). Patients with hypertension, diabetes mellitus, or atrial
fibrillation were excluded from the study. Informed consent was
obtained from all subjects before participating in the study in
accordance with the guidelines of Kanazawa University Hospital
Human Subjects Committee.
Evaluation of Cardiac Sympathetic Nerve Activity
Patients were instructed to fast on the day of the radionuclide
study and to continue fasting until the study was completed. No
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patients were taking reserpine or tricyclic antidepressants at the
time of the study. An intravenous injection of 120–140 MBq
123I-MIBG was given between 9:00 and 10:00 AM. Planar scinti-
graphic imaging in the anterior view and SPECT were performed
20 min (early) and 3 h (delayed) after 123I-MIBG injection. The
SPECT system (model 9300A; Toshiba, Tokyo, Japan) consisted
of a triple-head scintillation camera. The energy discrimination
was centered on 159 keV with a 20% window; a total of 60
projection images were obtained in a 64  64 matrix over a 360°
arc in 6° increments with 30-s acquisitions for each view. Tomo-
graphic images were reconstructed using a ramp filter with a
Butterworth filter (order, 8; cutoff frequency, 0.47 cycle/cm).
Attenuation correction was not performed.
Whole cardiac 123I-MIBG uptake was measured as the heart-to-
mediastinum activity ratio (H/M) on a planar image. The region of
interest (ROI) was drawn manually over the whole left ventricle,
and a rectangular ROI was set on the upper mediastinum in the
early image and then the same ROIs were applied to the delayed
image. Values of H/M were calculated by dividing the count
density of the whole heart by that of the mediastinum. The washout
rate was calculated using the following equation: washout rate 
(Ec  Dc)  100/Ec, where Ec is the early cardiac count density
and Dc is the decay-corrected delayed cardiac count density.
Polar maps of all patients with HCM were divided into 20
segments (Fig. 1). An ROI was placed on each of the 20 segments.
The maximal count in the polar map representing the entire left
ventricular myocardium was normalized to 100, and the segmental
early uptake was calculated as a ratio of the maximal count. In
addition, the early uptake, delayed uptake, and washout rate of
each segment were obtained. The SDs of the early uptake, delayed
uptake, and washout rate in 20 segments and the differences of
maximal and minimal values (dispersions) of segmental early
uptake, delayed uptake, and washout rate were calculated as indi-
ces of regional 123I-MIBG variation.
Echocardiography
A transthoracic echocardiographic examination was performed
within 1 wk of the 123I-MIBG injection in all patients with HCM.
Standard M-mode and 2-dimensional echocardiographic studies,
including long-axis, short-axis, and apical 4-chamber views, were
performed to identify and quantify morphologic features of the left
ventricular dimensions. The thickness of the septum and thickness
of the left ventricular posterior wall were measured at the level of
the tips of the mitral valve leaflets. The fractional shortening was
calculated as the difference in end-diastolic and end-systolic di-
mensions divided by the end-diastolic dimension.
Statistical Analysis
Values are expressed as the mean  SD. Differences between
groups were analyzed by the Student unpaired t test. Categoric data
were compared using 2 analysis. Correlation was assessed by
linear regression analysis and the Pearson correlation coefficient.
The relationship between various 123I-MIBG scintigraphic vari-
ables and the percentage of fractional shortening was examined by
multiple regression analysis. Only variables with P  0.10 in the
univariate analysis were included in the stepwise regression anal-
ysis. P  0.05 was considered statistically significant.
RESULTS
Baseline Characteristics of Study Patients
The clinical and echocardiographic data of the patients
with HCM are summarized in Table 1. The number of
patients in the New York Heart Association functional
classes I, II, III, and IV were 14, 9, 2, and 0, respectively.
TABLE 1
Baseline Characteristics of HCM Patients
Characteristic n (%)
HCM patients 25




Family history of HCM 16 (64)
Family history of SCD 11 (44)
History of chest pain 9 (36)
History of syncope 2 (8)
VT on Holter ECG 4 (16)







IVST (mm) 17.8  3.5
PWT (mm) 13.4  3.0
IVST/PWT 1.36  0.31
LAD (mm) 39.1  7.0
LVDd (mm) 47.1  6.7
LVDs (mm) 29.0  7.8
FS (%) 39.0  10.2
SCD  sudden cardiac death; VT  ventricular tachycardia;
ECG  electrocardiogram; NYHA  New York Heart Association;
IVST interventricular septal thickness; PWT posterior wall thick-
ness; LAD  left atrial dimension; LVDd  left ventricular end-
diastolic dimension; LVDs  left ventricular end-systolic dimension;
FS  fractional shortening.
FIGURE 1. Left ventricular myocardium is divided into 20
segments, and uptake and washout rates in each section were
determined.
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The main left ventricular hypertrophy was present in the
anteroseptal wall in 19 patients (76%), in the apex in 2
patients (8%), and globally in 4 patients (16%).
123I-MIBG Scintigraphic Data
123I-MIBG scintigraphic data in patients with HCM and
control subjects are summarized in Table 2. The early
uptake ratio of heart and mediastinum (early H/M) did not
differ between the 2 groups. The delayed uptake ratio of
heart and mediastinum (delayed H/M) was significantly
lower, whereas the washout rate of the whole heart was
significantly higher in the HCM group than in the control
group.
Polar maps of a control subject and a patient with HCM
are shown in Figure 2. The regional variation, early uptake
dispersion, SD of the early uptake, washout rate dispersion,
and SD of the washout rate did not differ between the 2
groups. The delayed uptake dispersion and SD of the de-
layed uptake were smaller in HCM patients than in the
control group. No differences were found between these
variables in HCM patients with and without chest pain.
The region of maximal early uptake was the anterior or
anterolateral wall in almost all patients with HCM and
control subjects (HCM, 84%; control, 94%; not significant)
(Fig. 3A). On the contrary, minimal early uptake was ob-
tained frequently in the inferior or inferoseptal wall in
patients with HCM and control subjects (HCM, 56%; con-
trol, 80%; not significant). The region of maximal delayed
uptake was the anterior or anterolateral wall in almost all
patients with HCM and control subjects (HCM, 68%; con-
trol, 100%; not significant). On the contrary, the region of
minimal delayed uptake was the inferoseptal or inferior wall
in patients with HCM in contrast to the anteroseptal or
inferoseptal wall in control subjects, with a difference in
TABLE 2
123I-MIBG Scintigraphic Data
Parameter HCM Control P
H/M
Early 1.96  0.22 2.08  0.12 NS
Delayed 1.93  0.20 2.17  0.30 0.0077
WR 0.19  0.06 0.09  0.04 0.0001
Dispersion (%)
EU 35.2  9.6 39.2  5.7 NS
DU 38.3  7.9 47.9  7.5 0.0024
WR 42.3  17.9 35.2  12.4 NS
SD (%)
Regional EU 9.9  2.5 11.0  2.0 NS
Regional DU 10.8  2.2 14.0  2.5 0.0007
Regional WR 10.8  4.1 9.5  3.0 NS
NS  not significant; WR  washout rate; EU  early uptake;
DU  delayed uptake.
FIGURE 2. Polar maps of control subject
(early image [A] and delayed image [B]) and
patient with HCM (early image [C] and de-
layed image [D]).
HETEROGENEITY OF 123I-MIBG UPTAKE IN HCM • Shimizu et al. 17
distribution between the 2 groups (P  0.0093). The region
of maximal washout rate was the inferior or inferolateral
wall in 60% of the patients with HCM, whereas it was the
anteroseptal or anterior wall in 70% of the control subjects
(P  0.0047) (Fig. 3B). The minimal regional washout rate
showed no specific region in either group.
Relationships Between 123I-MIBG Scintigraphic and
Echocardiographic Variables in Patients with HCM
The correlation between 123I-MIBG scintigraphic and
echocardiographic variables in patients with HCM are sum-
marized in Table 3. The early H/M and washout rate of the
whole heart did not correlate with the left ventricular end-
diastolic dimension, the left ventricular end-systolic dimen-
sion, or the percentage of fractional shortening. However,
the delayed H/M, the early uptake dispersion, and the SD of
early uptake showed good correlation with the left ventric-
ular end-diastolic dimension, the left ventricular end-sys-
tolic dimension, and the percentage of fractional shortening
(Fig. 4). The delayed uptake dispersion did not correlate
with these parameters, and the SD of delayed uptake cor-
related with the left ventricular end-systolic dimension and
the percentage of fractional shortening. The washout rate
dispersion and the SD of the washout rate showed only a
weak correlation with the left ventricular end-diastolic di-
mension but showed no significant correlation with the left
ventricular end-systolic dimension or the percentage of frac-
tional shortening. A stepwise regression analysis revealed
that the SD of the early uptake was the most powerful
determinant for the percentage of fractional shortening in
patients with HCM.
DISCUSSION
This study showed a correlation between regional vari-
ability of 123I-MIBG early uptake and cardiac function in
patients with HCM. MIBG is an analog of noradrenaline
and shares the same reuptake pathway within the cardiac
synapse. Previous studies have shown that sympathetic
nerve dysfunction, such as diabetes or transplanted heart,
FIGURE 3. Segment shows maximal early uptake (A) and max-
imal washout rate (B). Black bars  patients with HCM; white
bars control subjects. Segments shown in Figure 1 are identified
as follows: Ap  apical; AS  anteroseptal; AN  anterior; AL 
anterolateral; IL  inferolateral; IN  inferior; IS  inferoseptal.
TABLE 3
Probability Values and Correlation Coefficients Obtained in Simple Regression Analysis for 123I-MIBG Scintigraphic
Variables and Echocardiographic Indices in Patients with HCM
Parameter
LVDd LVDs FS
P r P r P r
H/M
Early NS NS NS
Delayed 0.0094 0.509 0.0077 0.520 0.0373 0.418
WR NS NS NS
Dispersion
EU 0.0005 0.649 0.0002 0.681 0.0096 0.507
DU NS NS NS
WR 0.0480 0.399 NS NS
SD
Regional EU 0.0011 0.613 0.0001 0.729 0.0018 0.592
Regional DU NS 0.0078 0.520 0.0113 0.498
Regional WR 0.0310 0.432 NS NS
LVDd  left ventricular end-diastolic dimension; LVDs  left ventricular end-systolic dimension; FS  fractional shortening; NS  not
significant; WR  washout rate; EU  early uptake; DU  delayed uptake.
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involves reduced early uptake of 123I-MIBG (8,9). These
reports indicate that early uptake reflects mainly neural up-
take (uptake 1). Ungerer et al. (10) reported that uptake 1
density and the tissue norepinephrine content showed
marked regional variation in the left ventricle of patients
with dilated cardiomyopathy. However, regional varia-
tions in uptake 1 density or the norepinephrine content in
the heart with HCM are unclear. Moreover, the relation-
ship between regional variation of cardiac sympathetic
nerve activity and cardiac function in HCM is also un-
known. In this study, the early uptake dispersion and the
SD of early uptake correlated with the left ventricular
volumes and the percentage of fractional shortening in
patients with HCM—that is, patients with larger regional
variations of early uptake after 123I-MIBG injections had
larger left ventricular volumes and a lower percentage of
fractional shortening.
The attenuation effect attributed to the left ventricular
size should be considered first. However, this effect may be
very small. The early uptake dispersion and the SD of the
early uptake correlated not only with the left ventricular
volumes but also with the percentage of fractional shorten-
ing in patients with HCM, and the percentage of fractional
shortening was not significantly correlated with the left
ventricular volumes. Even after the exclusion of inferior and
inferoseptal segments from the analysis, the early uptake
dispersion and the SD of the early uptake correlated signif-
icantly with the left ventricular volumes and the percentage
of fractional shortening (data not shown). These results
suggest that regional variability of early uptake was caused
FIGURE 4. (A) Relationship between
early uptake dispersion and percentage of
fractional shortening. (B) Relationship be-
tween SD of segmental early uptake and
percentage of fractional shortening.
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by cardiac dysfunction not by a change in the left ventric-
ular volume.
Two possibilities may account for these observations.
The first is an increase in heterogeneity by a greater increase
in uptake in the high-uptake region, in which myocardial
damage is small because of a compensation for cardiac
dysfunction. In this condition, the washout rate in the high-
uptake region may increase and the regional variability of
the washout rate may also increase. However, we reasoned
that this possibility is unlikely because there is no correla-
tion between variability indices of the washout rate, the
washout rate dispersion and the SD of the washout rate, and
the percentage of fractional shortening. The second possi-
bility is an increase in heterogeneity by a greater decrease in
uptake in the low-uptake region. Whole cardiac early uptake
(i.e., early H/M) in patients with HCM did not differ from
that in control subjects. Because myocardial mass in pa-
tients with HCM was larger than that in control subjects,
early uptake per myocardial unit was decreased in patients
with HCM compared with that in the control group. The
maximal early uptake region was the anterior or anterolat-
eral wall in patients with HCM and control subjects. From
these results, we hypothesize that the early uptake in the
anteroseptal wall, which was the most hypertrophied region,
in patients with HCM was decreased. In a study using PET,
Li et al. (11) reported that neuronal uptake of catechol-
amines decreased in hypertrophied myocardium of patients
with HCM. This report supports our hypothesis. The fol-
lowing findings suggest myocardial damage in the septum
of patients with HCM: Systolic thickening and cyclic vari-
ation of integrated backscatter of the interventricular septum
in HCM were small (12), washout rate in the interventric-
ular septum in HCM increased (13), and regional wall
motion abnormalities during dobutamine infusion occur
more frequently in hypertrophied segments (14). In this
study, the region of maximal washout rate was the inferior
wall or inferolateral wall in patients with HCM in contrast
to the anterior or anteroseptal wall in control subjects. From
these findings, we suggest that the left ventricular systolic
function may be preserved when contractility of inferior
(posterior) wall is good. However, the left ventricular sys-
tolic function may be decreased when myocardial damage
advances to the inferior wall in addition to the interventric-
ular septum.
In this study, there was no significant difference in the
early H/M and the early uptake variability indices between
patients with HCM and control subjects. However, all of
these indices are relative values. Evaluations that are based
on absolute values with PET or other methods will be
necessary in future studies. 123I-MIBG scintigraphy has
been reported to be useful for the prognosis of patients with
heart failure or dilated cardiomyopathy (15–17). The rela-
tionship between the heterogeneity of cardiac sympathetic
nerve activity and the prognosis of patients with HCM
should also be studied in the future. In addition, our study
included relatively few patients. Additional studies with a
larger number of patients are necessary to confirm and
clarify our results.
CONCLUSION
The dispersion and the SD of the early uptake, the indices
of regional 123I-MIBG variation, showed good correlation
with the left ventricular dimensions and the percentage of
fractional shortening in patients with HCM. The SD of the
early uptake was a powerful statistical determinant for the
percentage of fractional shortening in these patients. The
heterogeneity of regional cardiac sympathetic nerve activity
may be correlated with cardiac dysfunction in patients with
HCM.
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